Clinical impacts of the concomitant use of L-asparaginase and total parenteral nutrition containing L-aspartic acid in patients with acute lymphoblastic leukemia

INTRODUCTION: L-asparaginase (ASNase) depletes L-asparagine and causes the death of leukemic cells, making it a mainstay for the treatment of acute lymphoblastic leukemia (ALL). However, ASNase's activity can be inhibited by L-aspartic acid (Asp), which competes for the same substrate and reduc...

Descripción completa

Detalles Bibliográficos
Autores principales: Ko, Minoh, Kim, Myeong Gyu, Yoon, Sung-Soo, Kim, In-Wha, Suh, Sung Yun, Cho, Yoon-Sook, Oh, Jung Mi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Nutrition
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10106764/
https://www.ncbi.nlm.nih.gov/pubmed/37077904
http://dx.doi.org/10.3389/fnut.2023.1122010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10106764/
https://www.ncbi.nlm.nih.gov/pubmed/37077904
http://dx.doi.org/10.3389/fnut.2023.1122010

Ejemplares similares